scispace - formally typeset
Journal ArticleDOI

Mucins in cancer: Protection and control of the cell surface

TLDR
Mucins — large extracellular proteins that are heavily glycosylated with complex oligosaccharides — establish a selective molecular barrier at the epithelial surface and engage in morphogenetic signal transduction.
Abstract
Mucins — large extracellular proteins that are heavily glycosylated with complex oligosaccharides — establish a selective molecular barrier at the epithelial surface and engage in morphogenetic signal transduction. Alterations in mucin expression or glycosylation accompany the development of cancer and influence cellular growth, differentiation, transformation, adhesion, invasion and immune surveillance. Mucins are used as diagnostic markers in cancer, and are under investigation as therapeutic targets for cancer.

read more

Citations
More filters
Journal ArticleDOI

Hyaluronan: from extracellular glue to pericellular cue

TL;DR: This work highlights a key role for interactions between hyaluronan and tumour cells in several aspects of malignancy and indicates the possibility of new therapeutic strategies.
Journal ArticleDOI

Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System

TL;DR: Using an EGFP-tagged endonuclease-deficient Cas9 protein and a structurally optimized small guide (sg) RNA, robust imaging of repetitive elements in telomeres and coding genes in living cells is demonstrated by repurposing the bacterial CRISPR/Cas system.
Journal ArticleDOI

Glycans in cancer and inflammation — potential for therapeutics and diagnostics

TL;DR: This review highlights changes in glycosylation associated with cancer and chronic inflammation and new therapeutic and diagnostic strategies that are based on the underlying glycobiology.
Journal ArticleDOI

Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.

TL;DR: The protective barrier properties of mucus secretions, how mucus affects the fate of orally administered nanoparticles, and recent developments in nanoparticles engineered to penetrate the mucus barrier are addressed.
Journal ArticleDOI

The sweet and sour of cancer: glycans as novel therapeutic targets.

TL;DR: A growing body of evidence supports crucial roles for glycans at various pathophysiological steps of tumour progression, and increased understanding of these roles sets the stage for developing pharmaceutical agents that target these molecules.
References
More filters
Journal ArticleDOI

Reactivity of a monoclonal antibody with human ovarian carcinoma.

TL;DR: A murine monoclonal antibody (OC125) has been developed that reacts with each of six epithelial ovarian carcinoma cell lines and with cryopreserved tumor tissue from 12 of 20 ovarian cancer patients, but does not bind to a variety of nonmalignant tissues, including adult and fetal ovary.
Journal ArticleDOI

Molecular cloning and expression of human Tumor-associated Polymorphic Epithelial Mucin

TL;DR: The full sequence for PEM, as deduced from cDNA sequences, is reported, with length variations in the tandem repeat result in PEM being an expressed variable number tandem repeat locus.
Journal ArticleDOI

Colorectal cancer in mice genetically deficient in the mucin Muc2.

TL;DR: Muc2 is involved in the suppression of colorectal cancer and frequently developed adenomas in the small intestine that progressed to invasive adenocarcinoma, as well as rectal tumors.
Journal ArticleDOI

Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

TL;DR: Heparin treatment attenuates tumor metastasis in mice by inhibiting P-selectin-mediated interactions of platelets with carcinoma cell-surface mucin ligands, and it is suggested that heparin therapy for metastasis prevention in humans be revisited, with these mechanistic paradigms in mind.
Journal Article

Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin

TL;DR: Adversity affinity purified by antibody 19-9 from the serum of a cancer patient belonging to the Le(a-b+) blood group contains Leb antigen, consistent with the multiple antigenic specificities exhibited by mucins.
Related Papers (5)